Metastatic breast cancer means the cancer has spread beyond the breast and nearby lymph nodes

Metastatic breast cancer is breast cancer that has traveled to distant parts of the body—most commonly the bones, lungs, liver, or brain. It is also called stage 4 breast cancer. The cancer cells that appear in these distant sites came from the original tumor in the breast, not from a new cancer that started there.

This is different from locally advanced breast cancer, which has spread to the chest wall or lymph nodes near the breast but not to distant organs. Metastatic cancer is also different from a recurrence—cancer that returns after treatment—though recurrence can become metastatic if it spreads beyond the original site.

The distinction matters because metastatic breast cancer is treated differently than early-stage disease. The goal of treatment shifts from trying to cure the cancer to managing it as a long-term condition, controlling symptoms, and extending survival. Some people live for years or even decades with metastatic breast cancer, depending on the type of cancer, where it has spread, and how it responds to treatment.

Key Takeaways

  • Metastatic breast cancer has spread to organs or bones far from the breast, making it stage 4 disease.
  • The cancer cells in distant sites came from the original breast tumor, not from new cancers that started there.
  • Treatment focuses on managing the cancer over time rather than curing it, though some people survive for many years.
  • Metastatic breast cancer is diagnosed through imaging scans (CT, MRI, bone scan, or PET scan) that show where the cancer has spread.
  • Survival time varies widely based on the type of breast cancer, where it has spread, and how well it responds to treatment.

How metastatic breast cancer develops

Metastatic breast cancer can develop in two ways. Some people are diagnosed with stage 4 disease at their first breast cancer diagnosis—this is called de novo metastatic breast cancer. Others develop metastatic disease months or years after being treated for early-stage breast cancer. This is called a recurrence or metastatic recurrence.

Cancer cells spread through the bloodstream or lymphatic system. A single cell from the original breast tumor can travel to a distant organ, settle there, and begin to grow. This process can take months or years, which is why metastatic disease sometimes appears long after the original cancer was treated.

The risk of metastatic recurrence depends on the characteristics of the original tumor—its size, grade, hormone receptor status, and whether it was HER2-positive. It also depends on the treatment received and how well the cancer responded. Some types of breast cancer are more likely to spread than others.

Where metastatic breast cancer spreads

Breast cancer most often spreads to the bones, followed by the lungs, liver, and brain. It can also spread to the skin, adrenal glands, or other organs, though this is less common. The location where cancer spreads affects the symptoms a person experiences and the treatment options available.

Bone metastases are the most frequent site. Cancer in the bones can cause pain, fractures, or spinal cord compression. Lung metastases may cause shortness of breath, cough, or chest pain. Liver metastases can cause fatigue, abdominal swelling, or jaundice. Brain metastases may cause headaches, balance problems, or cognitive changes.

A person can have metastases in one location or in multiple locations at the same time. The pattern of spread is sometimes called the "metastatic burden"—the total amount and location of cancer in the body. A larger burden generally means more aggressive treatment may be needed.

How metastatic breast cancer is diagnosed

Metastatic breast cancer is found through imaging scans ordered by an oncologist. The most common scans are CT scans (detailed X-ray images), MRI scans (magnetic resonance images), bone scans (which use a radioactive tracer to find bone metastases), and PET scans (which show areas of high metabolic activity where cancer is likely present).

A biopsy—taking a small tissue sample from a metastatic site—may be done to confirm that the distant cancer is breast cancer and to test its hormone receptor and HER2 status. This information guides treatment decisions. Blood tests may also be ordered to check liver and kidney function and to measure tumor markers (substances released by cancer cells), though tumor markers alone cannot diagnose metastatic disease.

If you have a history of breast cancer and develop new symptoms—persistent pain, shortness of breath, unexplained weight loss, or neurological changes—tell your oncologist. These symptoms warrant imaging to check for metastatic spread.

Types of metastatic breast cancer and their characteristics

Metastatic breast cancer is classified by the same hormone and HER2 characteristics as early-stage disease. Hormone receptor-positive (HR+) metastatic breast cancer grows in response to estrogen or progesterone and is often treated with hormone therapy. HER2-positive metastatic breast cancer has too much of a protein called HER2 and responds to targeted drugs like trastuzumab (Herceptin). Triple-negative metastatic breast cancer lacks hormone receptors and HER2 and is typically treated with chemotherapy.

The subtype of the cancer—whether it is luminal A, luminal B, HER2-enriched, or basal-like—also influences prognosis and treatment. Some subtypes tend to spread more aggressively or to specific organs. Your pathology report will specify these characteristics.

In recent years, genetic testing for mutations in genes like BRCA1, BRCA2, and others has become more common in metastatic disease. These mutations can guide treatment choices and may affect family members' cancer risk.

Treatment approaches for metastatic breast cancer

Treatment for metastatic breast cancer depends on the subtype, where the cancer has spread, prior treatments, and overall health. Hormone therapy is often the first choice for HR+ disease and can control cancer for months or years. Chemotherapy is used when hormone therapy is not effective or when the cancer is aggressive. Targeted therapies like HER2-directed drugs, CDK4/6 inhibitors, or mTOR inhibitors are used based on the cancer's characteristics.

Immunotherapy drugs that help the immune system fight cancer are increasingly used, particularly for triple-negative disease. Radiation therapy may be used to treat pain or prevent complications from metastases in specific locations, such as the spine or brain.

Treatment is often ongoing. If a cancer stops responding to one drug, another is tried. The goal is to keep the cancer under control while managing side effects and maintaining quality of life. Some people take breaks between treatments; others switch to a different drug without a break.

Survival and prognosis with metastatic breast cancer

Survival time with metastatic breast cancer varies widely. Some people live for several years or longer; others have a shorter survival. Factors that influence prognosis include the subtype of cancer (HR+ disease generally has a longer survival than triple-negative), where the cancer has spread, how well it responds to treatment, and overall health.

Median survival—the point at which half of people live longer and half live shorter—is not a prediction for any individual. Two people with the same diagnosis can have very different outcomes. Advances in treatment over the past decade have extended survival for many people with metastatic breast cancer.

It is important to discuss prognosis and realistic goals with your oncologist. Some people focus on extending life; others prioritize quality of life and symptom control. Both are valid approaches, and treatment can often be tailored to match your priorities.

Living with metastatic breast cancer

Metastatic breast cancer is a chronic condition that requires ongoing medical care. Regular imaging scans and blood work monitor how the cancer is responding to treatment. Appointments with your oncology team may be frequent, especially when starting a new treatment or if the cancer is not responding well.

Side effects from treatment—fatigue, nausea, joint pain, or cognitive changes—are common and can affect daily life. Talking with your care team about side effects is important; many can be managed or reduced. Palliative care—treatment focused on comfort and symptom control—can be used alongside cancer treatment at any stage.

Support from mental health professionals, social workers, support groups, and loved ones is part of managing metastatic disease. Many cancer centers offer counseling, support groups, and resources for people living with metastatic cancer.

Frequently Asked Questions

Is metastatic breast cancer the same as stage 4?

Yes. Metastatic breast cancer is stage 4 breast cancer. The terms are used interchangeably. Stage 4 means the cancer has spread to distant organs or bones beyond the breast and nearby lymph nodes.

Can metastatic breast cancer be cured?

Metastatic breast cancer is not typically cured, but it can be controlled with treatment for months or years. The goal is to slow the cancer's growth, manage symptoms, and extend survival while maintaining quality of life. Some people live for many years with metastatic disease.

What is the difference between metastatic breast cancer and a recurrence?

A recurrence is cancer that returns after treatment, usually in the same breast or nearby lymph nodes. Metastatic disease means the cancer has spread to distant organs. A recurrence can become metastatic if it spreads beyond the original site.

How often do I need scans if I have metastatic breast cancer?

Scan frequency depends on the type of cancer, the treatment being used, and how the cancer is responding. Some people have scans every 8 to 12 weeks; others have them less often. Your oncologist will recommend a schedule based on your situation.

Can I work while being treated for metastatic breast cancer?

Many people continue to work during treatment, though the ability to do so depends on the type of treatment, side effects, and the demands of the job. Some people reduce hours or take medical leave during intensive treatment. Talk with your employer about accommodations and with your care team about what is realistic for you.